Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zwitter

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 2003
The significance of adrenal metastases from lung carcinomaI Kocijancic, K Vidmar, M Zwitter, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancerMatjaz Zwitter, Viljem Kovac, Uros Smrdel, et al.
Radiology and Oncology|March 4, 2014
Glioblastoma patients in Slovenia from 1997 to 2008Uros Smrdel, Viljem Kovac, Mara Popovic, et al.
Neoplasma|January 12, 2018
PD-L1 expression can be regarded as prognostic factor for survival of non-small cell lung cancer patients after chemoradiotherapyM Vrankar, M Zwitter, I Kern, et al.
Family Practice|May 10, 2003
GPs facing reluctant and demanding patients: analysing ethical justificationsStefan Bremberg, Tore Nilstun, Vili Kovac, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 24, 2009
Gemcitabine in brief versus prolonged low-dose infusion, both combined with cisplatin, for advanced non-small cell lung cancer: a randomized phase II clinical trialMatjaz Zwitter, Viljem Kovac, Uros Smrdel, et al.
International Journal of Radiation Oncology, Biology, Physics|May 23, 2002
Dorothy Reed and Hodgkin's disease: a reflection after a centuryMatjaz Zwitter, Joel R Cohen, Ann Barrett, et al.
JMIR Serious Games|April 13, 2026
Analysis of Machine Learning-Based Investigation Into Multivariate Factors of Team Performance in Serious Games: Cross-Sectional Retrospective StudyGruyff Germain Abdul-Rahman, Freark de Lange, Andrej Zwitter, et al.
Anti-Cancer Drugs|May 11, 2010
Two schedules of chemotherapy for patients with non-small cell lung cancer in poor performance status: a phase II randomized trialMatjaz Zwitter, Viljem Kovac, Mirjana Rajer, et al.
Radiology and Oncology|December 2, 2014
Induction gemcitabine in standard dose or prolonged low-dose with cisplatin followed by concurrent radiochemotherapy in locally advanced non-small cell lung cancer: a randomized phase II clinical trialMartina Vrankar, Matjaz Zwitter, Tanja Bavcar, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 2003
The significance of adrenal metastases from lung carcinomaI Kocijancic, K Vidmar, M Zwitter, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancerMatjaz Zwitter, Viljem Kovac, Uros Smrdel, et al.
Radiology and Oncology|March 4, 2014
Glioblastoma patients in Slovenia from 1997 to 2008Uros Smrdel, Viljem Kovac, Mara Popovic, et al.
Neoplasma|January 12, 2018
PD-L1 expression can be regarded as prognostic factor for survival of non-small cell lung cancer patients after chemoradiotherapyM Vrankar, M Zwitter, I Kern, et al.
Family Practice|May 10, 2003
GPs facing reluctant and demanding patients: analysing ethical justificationsStefan Bremberg, Tore Nilstun, Vili Kovac, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 24, 2009
Gemcitabine in brief versus prolonged low-dose infusion, both combined with cisplatin, for advanced non-small cell lung cancer: a randomized phase II clinical trialMatjaz Zwitter, Viljem Kovac, Uros Smrdel, et al.
International Journal of Radiation Oncology, Biology, Physics|May 23, 2002
Dorothy Reed and Hodgkin's disease: a reflection after a centuryMatjaz Zwitter, Joel R Cohen, Ann Barrett, et al.
JMIR Serious Games|April 13, 2026
Analysis of Machine Learning-Based Investigation Into Multivariate Factors of Team Performance in Serious Games: Cross-Sectional Retrospective StudyGruyff Germain Abdul-Rahman, Freark de Lange, Andrej Zwitter, et al.
Anti-Cancer Drugs|May 11, 2010
Two schedules of chemotherapy for patients with non-small cell lung cancer in poor performance status: a phase II randomized trialMatjaz Zwitter, Viljem Kovac, Mirjana Rajer, et al.
Radiology and Oncology|December 2, 2014
Induction gemcitabine in standard dose or prolonged low-dose with cisplatin followed by concurrent radiochemotherapy in locally advanced non-small cell lung cancer: a randomized phase II clinical trialMartina Vrankar, Matjaz Zwitter, Tanja Bavcar, et al.
Pageof 6